Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

@article{Kawaguchi2013ClinicalIO,
  title={Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer},
  author={T. Kawaguchi and S. Komatsu and D. Ichikawa and R. Morimura and M. Tsujiura and H. Konishi and H. Takeshita and H. Nagata and T. Arita and S. Hirajima and A. Shiozaki and H. Ikoma and K. Okamoto and T. Ochiai and H. Taniguchi and E. Otsuji},
  journal={British Journal of Cancer},
  year={2013},
  volume={108},
  pages={361 - 369}
}
Background:Several recent studies have demonstrated that microRNAs (miRNAs) are stably detectable in plasma/serum. We tested miR-221 and miR-375, which are frequently reported to be highly and poorly expressed in pancreatic cancer (PCa), as candidates for plasma biomarkers in PCa.Methods:This study was divided into three parts: (1) Confirmation of higher miR-221 levels in primary PCa tissue and cell lines than normal pancreatic tissues. (2) Evaluation of plasma miR-221 and miR-375… Expand
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer
Circulating microRNAs in plasma of patients with gastric cancers
Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Circulating microRNAs as stable blood-based markers for cancer detection
Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma
Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer.
...
1
2
3
4
5
...